Literature DB >> 1878125

Staphylococcal-enterotoxin-dependent cell-mediated cytotoxicity.

M Dohlsten1, G Hedlund, T Kalland.   

Abstract

T cells equipped with sophisticated TCR and MHC recognition structures, an efficient cytokine communication network and lethal cytotoxic effector functions constitute one of the bulwarks of the mammalian immune system. However, infective agents have developed strategies to undermine T-cell immunity; for example, certain bacterial toxins serve as 'superantigens' by binding to preserved determinants on MHC class-II-encoded proteins and activating T cells expressing particular sequences of TCR V beta gene products. In this paper, Mikael Dohlsten and colleagues present evidence suggesting that these bacterial superantigens direct T cells to eradicate MHC class-II-expressing antigen-presenting cells, thus counteracting specific T-cell functions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1878125     DOI: 10.1016/S0167-5699(05)80043-X

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  15 in total

1.  Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.

Authors:  P A Lando; M Dohlsten; G Hedlund; T Brodin; D Sansom; T Kalland
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

Review 2.  Genetically engineered superantigens in experimental tumor therapy.

Authors:  P Antonsson; J Hansson; T Kalland; P A Lando; L Ohlsson; E Schad; A Svensson; M Dohlsten
Journal:  Springer Semin Immunopathol       Date:  1996

3.  T-cell stimulation and cytokine release induced by staphylococcal enterotoxin A (SEA) and the SEAD227A mutant.

Authors:  U Holzer; T Orlikowsky; C Zehrer; W Bethge; M Dohlsten; T Kalland; D Niethammer; G E Dannecker
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

4.  Genetically engineered superantigens as tolerable antitumor agents.

Authors:  J Hansson; L Ohlsson; R Persson; G Andersson; N G Ilbäck; M J Litton; T Kalland; M Dohlsten
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 5.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

6.  Frequency of toxic shock syndrome toxin- and enterotoxin-producing clinical isolates of Staphylococcus aureus.

Authors:  N Lehn; E Schaller; H Wagner; M Krönke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-01       Impact factor: 3.267

7.  Altered antigen-presenting capacity of human monocytes after phagocytosis of bacteria.

Authors:  J Pryjma; J Baran; M Ernst; M Woloszyn; H D Flad
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 8.  Relevance of the T cell receptor for immunotherapy of cancer.

Authors:  E Weidmann; M Trucco; T L Whiteside
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

9.  Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.

Authors:  M Dohlsten; G Hedlund; E Akerblom; P A Lando; T Kalland
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

10.  Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity.

Authors:  H Belfrage; P Bhiladvala; G Hedlund; M Dohlsten; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.